F-group (family)
7563.1.1.6 LSDAT_euk
Ligands and drugs
715
Member domains
263
with ligand contacts (≤ 4 Å)
36.8% of members
6
with DrugDomain annotations
0.8% of members
4
with a DrugBank compound
0.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7563.1.1.6 belongs to X-group 7563 MCP/YpsA-related, which has 11 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02059 | AR6 | Adenosine-5-Diphosphoribose | 2 |
| DB00825 | — | — | 1 |
| DB01016 | — | Glyburide | 1 |
| DB01744 | — | Camphor | 1 |
| DB09061 | — | Cannabidiol | 1 |
| DB11345 | — | — | 1 |
| DB11755 | — | Tetrahydrocannabivarin | 1 |
| DB14011 | — | — | 1 |
| DB14123 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CAmetal | CALCIUM ION | 112 |
| CLR | CHOLESTEROL | 56 |
| APR | ADENOSINE-5-DIPHOSPHORIBOSE | 53 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 20 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 17 |
| KX7 | Icilin | 16 |
| ULO | nonyl(oxo)di(propan-2-yl)-lambda~5~-phosphane | 12 |
| LQ7 | N-(3-aminopropyl)-2-[(3-methylphenyl)methoxy]-N-[(thiophen-2-yl)methyl]benzamide | 8 |
| ZNmetal | ZINC ION | 7 |
| AR6 | [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL[HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE | 6 |
| A2R | [(2R,3R,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3-HYDROXY-4-(PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL [(2R,3S,4R,5R)-3,4,5-TRIHYDROXYTETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN DIPHOSPHATE | 5 |
| NAmetal | SODIUM ION | 5 |
| 9PE | (1R)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(heptanoyloxy)methyl]ethyl octadecanoate | 4 |
| A1AIY | (8R)-8-[4-(trifluoromethyl)phenyl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]-5,8-dihydro-1,7-naphthyridine-7(6H)-carboxamide | 4 |
| CV1 | (2R,3R,4S,5R,13R,14S,15R,16R)-24-amino-18-bromo-3,4,14,15-tetrahydroxy-7,9,11,25,26-pentaoxa-17,19,22-triaza-1-azonia-8,10-diphosphapentacyclo[18.3.1.1^2,5^.1^13,16^.0^17,21^]hexacosa-1(24),18,20,22-tetraene-8,10-diolate 8,10-dioxide | 4 |
| DVT | DECAVANADATE | 4 |
| MGmetal | MAGNESIUM ION | 4 |
| T14 | 3-{7-(trifluoromethyl)-5-[2-(trifluoromethyl)phenyl]-1H-benzimidazol-2-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene | 4 |
| UL9 | 3-isothiocyanatoprop-1-ene | 4 |
| UOO | (3R,4R,5R)-5-(6-amino-8-bromo-9H-purin-9-yl)-3,4,5-trihydroxypentyl [(2S,3S,4S,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl dihydrogen diphosphate (non-preferred name) | 4 |